PT  - JOURNAL ARTICLE
AU  - Ahamad, Mazbahul G.
AU  - Ahmed, Monir U.
AU  - Talukder, Byomkesh
AU  - Tanin, Fahian
TI  - Use of Unofficial Newspaper Data for COVID-19 Death Surveillance
AID  - 10.1101/2020.09.09.20191569
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.09.20191569
4099  - http://medrxiv.org/content/early/2020/09/11/2020.09.09.20191569.short
4100  - http://medrxiv.org/content/early/2020/09/11/2020.09.09.20191569.full
AB  - Objective To highlight the critical importance of unofficially reported newspaper-based deaths from coronavirus disease 2019 (COVID-19)–like illness (CLI) together with officially confirmed death counts to support improvements in COVID-19 death surveillance.Methods Both hospital-based official COVID-19 and unofficial CLI death counts were collected from daily newspapers between March 8 and August 22, 2020. We performed both exploratory and time-series analyses to understand the influence of combining newspaper-based CLI death counts with confirmed hospital death counts on the trends and forecasting of COVID-19 death counts. An autoregressive integrated moving average–based approach was used to forecast the number of weekly death counts for six weeks ahead.Results Between March 8 and August 22, 2020, 2,156 CLI deaths were recorded based on newspaper reporting for a count that was 55% of the officially confirmed death count (n = 3,907). This shows that newspaper reports tend to cover a significant number of COVID-19 related deaths. Our forecast also indicates an approximate total of 406 CLI expected for the six weeks ahead, which could contribute to a total of 2,413 deaths including 2,007 confirmed deaths expected from August 23 to October 3, 2020.Conclusions Analyzing existing trends in and forecasting the expected number of newspaper-based CLI deaths indicates yet-unreported COVID-19 death counts, which could be a critical source to estimate provisional COVID-19 death counts and mortality surveillance.Public Health Implications Considering unofficial newspaper-based CLI death counts is essential to identify COVID-19 death severity and surveillance needs to advance public health research efforts to prepare appropriate response strategies for low- and middle-income countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not sought as this study used publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and codes used in the study will be available at https://dataverse.harvard.edu/dataverse/mazbahulahamad after publication. https://dataverse.harvard.edu/dataverse/mazbahulahamad